N3 alkylated benzimidazole derivatives as MEK inhibitors

Details for Australian Patent Application No. 2004270166 (hide)

Owner Array BioPharma Inc.

Inventors Hurley, Brian T.; Lyssikatos, Joseph P.; Marlow, Allison L.; Koch, Kevin; Wallace, Eli M.

Agent Watermark

Pub. Number AU-A-2004270166

PCT Pub. Number WO2005/023251

Priority 10/652,733 29.08.03 US

Filing date 20 August 2004

Wipo publication date 17 March 2005

International Classifications

A61K 31/4184 (2006.01)

C07D 235/08 (2006.01) Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings

Event Publications

27 April 2006 PCT application entered the National Phase

  PCT publication WO2005/023251 Priority application(s): WO2005/023251

7 August 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004270167-Vegetation trimmer apparatus

2004270165-Anti-CD20 therapy of ocular disorders